According to Rich Coutinho of CBS New York, it’s …
Chemistry in the clubhouse.
It can extend winning streaks and snap losing streaks. The Mets have great chemistry, and that’s been been of the biggest reasons New York sits in second place in the competitive NL East.
And here I thought it was because of an MVP-caliber season from David Wright, offensive contributions from everyone else besides Ike Davis that are exceeding expectations, a resurgent Johan Santana helping the pitching look respectable when it was anticipated to be awful and an great deal of good fortune which has allowed the team to out-perform their Pythagorean record by a full five games.
But hey, if you wanna go with “chemistry,” be my guest.
Steven Matz underwent season-ending surgery on his left elbow today. The procedure was to reposition a compressed nerve in his elbow.
Matz, 26, has struggled over 13 starts, posting a 6.08 ERA with a 48/19 K/BB ratio in 66.2 innings. That line was, obviously, a function of the bum nerve in the bum elbow. Trouble aside, Matz is expected to be ready for Opening Day in 2018.
Back in April the Mariners designated outfielder Leonys Martin for assignment. He cleared waivers, accepted an assignment to Triple-A Tacoma and proceeded to hit .312/.352/.506 in 84 minor league games, leading to the Mariners calling him up on July 30.
In 19 games since then he’s hit a bit better than he did back in April, but not great: .230/.266/.426. So they just designated him for assignment again. The Rainers only have six more games this season, so he’s likely not going back there. Given that he’s arbitration eligible and the M’s are unlikely to tender him a contract, he’s likely to elect free agency once he clears waivers. Which he will, because he’s making nearly $5 million this year.
Odd year for Martin, who will likely be competing for a roster spot someplace next spring.